Skip to main content

Piper Sandler & Co.

SEC CIK
0000724683
Latest filing
Jul 28, 2026

DSGN holding history

Design Therapeutics, Inc. in every 13F filed by Piper Sandler & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings

Shares (Q4 2021)
0
Sold out in Q4 2021
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2021
Holdings of DSGN by Piper Sandler & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20210$00.0%−2,500−100.0%Sold outHolders
Q3 20212,500$37.0K0.1%+2,500NewHolders